Reduced Glomerular Progenitors Impair Regeneration in Aged Kidney

肾小球祖细胞减少会损害衰老肾脏的再生

基本信息

  • 批准号:
    9329346
  • 负责人:
  • 金额:
    $ 47.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-08-15 至 2021-03-31
  • 项目状态:
    已结题

项目摘要

The general population is living longer, precipitating the need to better understand the effects of aging on organ structure and function. Impaired kidney function is more common in the elderly, and the incidence of ESRD is increasing disproportionately in people > 65yrs. The goal of this grant proposal is to identify novel mechanisms underlying changes in the aging kidney, with a focus on the glomerulus, in particular both glomerular epithelial cell types. Kidney aging is typified by a progressive depletion of podocytes, which directly underlies the development of glomerulosclerosis and reduced kidney function. Terminally differentiated epithelial cells, called podocytes (podo) are unable to adequately proliferate, and therefore cannot replace themselves. Recently a large and compelling literature shows that in young adult and middle-aged kidneys, a subpopulation of neighboring glomerular parietal epithelial cells (PECs) serves as adult podo progenitors. We recently reported that PECs are also affected by aging; characterized by a decrease in total PEC number, with subpopulations of the remaining cells becoming senescent or undergoing mesenchymal transformation. This grant proposal will study the existing problem of age-related podo depletion, but in a completely new context, by addressing major knowledge gaps of PEC progenitors in the aging kidney and their inability to adequately replenish podo. New approaches will include our recently developed dual PEC-podo reporter mice that individually label and lineage trace PECs and podos within the same glomerulus, the use of an inducible PEC progenitor reporter mouse, and the use of primary PECs in culture derived from reporter mice of advanced age. Aim 1 will establish when, and at what rate, PEC progenitor number decreases with advancing age, and will test the hypothesis that progressive cellular senescence is a major cause of reduced PEC progenitors with aging. We will prove that by lowering senescence, PEC progenitor number will be higher, accompanied by higher podocyte density. Aim 2 will prove that the self-renewal of PEC progenitors is lower in aged mice compared to young mice, both chronically over the life span of the animal, and acutely in response to an abrupt decline in podo number in experimental FSGS. Studies will test the hypothesis that aged PEC proliferation is reduced due to de novo increases of the cell cycle inhibitors p21 and p16, and that this is secondary to increased oxidative stress. Aim 3 will show that aged PEC progenitors have a lower transdifferentiation capacity towards a podo fate, and test the hypothesis that this is in part due to the reprogramming of a subset of aged PECs to a mesenchymal fate, thereby limiting their ability to transdifferentiate into adult podos. We anticipate that the results will provide compelling evidence and candidate mechanisms for a new paradigm that the biology and functional roles of PEC progenitors are markedly altered in aged kidneys thus, leading to their inability to replenish podos. These studies will provide evidence for important functional changes in glomerular epithelial cells, which underlie detrimental changes in aged kidneys.
普通人群的寿命越来越长,这促使人们需要更好地了解老龄化对健康的影响

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stuart James Shankland其他文献

Stuart James Shankland的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stuart James Shankland', 18)}}的其他基金

The Intersection of Podocyte Disease and Aging
足细胞疾病与衰老的交叉点
  • 批准号:
    10733868
  • 财政年份:
    2023
  • 资助金额:
    $ 47.2万
  • 项目类别:
Targeting Podocyte-Endothelial Cell Crosstalk as a FSGS Therapy
靶向足细胞-内皮细胞串扰作为 FSGS 疗法
  • 批准号:
    10635547
  • 财政年份:
    2023
  • 资助金额:
    $ 47.2万
  • 项目类别:
Autocrine and paracrine podocyte signals decrease glomerular function/health in aged kidneys
自分泌和旁分泌足细胞信号会降低老年肾脏的肾小球功能/健康
  • 批准号:
    10698100
  • 财政年份:
    2022
  • 资助金额:
    $ 47.2万
  • 项目类别:
Kidney Aging Impairs Progenitor and Endocrine Function
肾脏老化损害祖细胞和内分泌功能
  • 批准号:
    10549835
  • 财政年份:
    2020
  • 资助金额:
    $ 47.2万
  • 项目类别:
Kidney Aging Impairs Progenitor and Endocrine Function
肾脏老化损害祖细胞和内分泌功能
  • 批准号:
    10341118
  • 财政年份:
    2020
  • 资助金额:
    $ 47.2万
  • 项目类别:
Cell specific delivery of novel therapies to enhance glomerular regeneration and repair
细胞特异性递送新疗法以增强肾小球再生和修复
  • 批准号:
    10675681
  • 财政年份:
    2020
  • 资助金额:
    $ 47.2万
  • 项目类别:
Cell specific delivery of novel therapies to enhance glomerular regeneration and repair
细胞特异性递送新疗法以增强肾小球再生和修复
  • 批准号:
    10247521
  • 财政年份:
    2020
  • 资助金额:
    $ 47.2万
  • 项目类别:
Cell specific delivery of novel therapies to enhance glomerular regeneration and repair
细胞特异性递送新疗法以增强肾小球再生和修复
  • 批准号:
    10414816
  • 财政年份:
    2020
  • 资助金额:
    $ 47.2万
  • 项目类别:
Rebuilding the glomerular filtration barrier by regenerating adult podocytes
通过再生成年足细胞重建肾小球滤过屏障
  • 批准号:
    9564892
  • 财政年份:
    2015
  • 资助金额:
    $ 47.2万
  • 项目类别:
Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomerular disease
肾小球旁细胞在肾小球疾病中充当肾小球上皮细胞祖细胞
  • 批准号:
    10436216
  • 财政年份:
    2014
  • 资助金额:
    $ 47.2万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了